Publication date: May 13, 2019
Listen to UCL/UCLH researcher Sarah Tabrizi talk about how researchers are set to carry out a large-scale, global study of a ground-breaking Huntington’s disease drug which is the first in the world to lower the level of the harmful huntingtin protein which causes Huntington’s.
Follow us on twitter: @UCLHresearch
Visit our website: www.uclhospitals.brc.nihr.ac.uk
|Branches of biology|
- Fresh Updates from First Huntingtin Lowering Study Publication
- Ground-breaking Huntington’s drug set for global study after successful first human trial
- Huntington’s disease: New drug successfully lowers levels of the abnormal protein